Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$3.74 USD
+0.01 (0.13%)
Updated May 9, 2024 04:00 PM ET
After-Market: $3.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -4.60 |
EPS Last Quarter | -1.80 |
Last EPS Surprise | 70.97% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -12.60 |
Next Year | -9.60 |
EPS (TTM) | -15.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.90M | 0.95M | 3.94M | 7.05M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.90M | 0.95M | 3.94M | 7.05M |
Low Estimate | 0.90M | 0.95M | 3.94M | 7.05M |
Year ago Sales | 4.41M | 2.92M | 13.37M | 3.94M |
Year over Year Growth Est. | -79.59% | -67.47% | -70.53% | 78.93% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -4.60 | -3.40 | -12.60 | -9.60 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -4.60 | -3.40 | -12.60 | -9.60 |
High Estimate | -4.60 | -3.40 | -12.60 | -9.60 |
Low Estimate | -4.60 | -3.40 | -12.60 | -9.60 |
Year ago EPS | -4.00 | -4.80 | -15.20 | -12.60 |
Year over Year Growth Est. | -15.00% | 29.17% | 17.11% | 23.81% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -4.60 | -3.40 | -12.60 | -9.60 |
7 Days Ago | -4.60 | -3.40 | -12.60 | -9.60 |
30 Days Ago | -4.60 | -3.40 | -12.60 | -9.60 |
60 Days Ago | -4.60 | -3.40 | -12.60 | -9.60 |
90 Days Ago | -5.00 | -3.80 | -17.40 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -4.60 | -3.40 | -12.60 | -9.60 |
Zacks Consensus Estimate | -4.60 | -3.40 | -12.60 | -9.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.80 | -5.20 | -4.80 | -4.00 | NA |
Estimate | -6.20 | -5.40 | -4.80 | -3.40 | NA |
Difference | 4.40 | 0.20 | 0.00 | -0.60 | 1.00 |
Surprise | 70.97% | 3.70% | 0.00% | -17.65% | 14.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more